Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 4/20 | 0.36 |
| ▸ | HTR2B | P41595 | 4/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10300817 | 0.78 | HTR2C (0.47) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL30036946 | 0.78 | HTR2C (0.47) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL7440746 | 0.78 | HTR2C (0.47) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL5853841 | 0.78 | HTR2C (0.41) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL2177894 | 0.76 | HTR2C (0.40) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL31546120 | 0.74 | CYP3A4 (0.33) | CYP3A4 | |
| SCHEMBL31546200 | 0.72 | CYP2A13 (0.36) | KDM1A | |
| SCHEMBL27201603 | 0.71 | PRKAB2 (0.39) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL4750478 | 0.68 | HTR2C (0.42) | HTR2CHTR2BBRD4KDM1ASLC6A2 | |
| SCHEMBL16463878 | 0.68 | HTR2C (0.39) | HTR2CHTR2BBRD4KDM1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090440-A1 | NOVEL CYCLIC ACETAL COMPOUNDS WITH ALDEHYDE OR KETONE FUNCTIONALITIES AND USES THEREOF | Structure Holdings, LLC (US) | 2025-03-20 | — | — | US | claimed |
| US-20250090440-A1 | NOVEL CYCLIC ACETAL COMPOUNDS WITH ALDEHYDE OR KETONE FUNCTIONALITIES AND USES THEREOF | Structure Holdings, LLC (US) | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090440-A1 | NOVEL CYCLIC ACETAL COMPOUNDS WITH ALDEHYDE OR KETONE FUNCTIONALITIES AND USES THEREOF | OR51E2, TAS2R5, TRPA1 | HTR2C 1533/4885HTR2B 1911/4885BRD4 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.